The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2022

Filed:

Sep. 07, 2017
Applicant:

Fgh Biotech, Inc., Houston, TX (US);

Inventors:

Motonari Uesugi, Osaka, JP;

John Kincaid, Hayward, CA (US);

Joel Huff, Spring Branch, TX (US);

Assignee:

FGH BIOTECH, INC., Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 401/04 (2006.01); A61P 9/10 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/12 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 35/00 (2018.01); C07D 401/04 (2013.01); C07D 405/14 (2013.01);
Abstract

Provided herein are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions in treating a condition, disease, or disorder associated with abnormal activation of the SREBP pathway, including metabolic disorders such as obesity, cancer, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD) wherein the compound is according to Formula (I).


Find Patent Forward Citations

Loading…